Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (Q63830910)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis |
clinical trial |
Statements
PALACE-1 (English)
0 references
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis (English)
0 references
2 June 2010
0 references
27 April 2012
0 references
504
0 references
18 year
0 references